AKT2 Modulates Astrocytic Nicotine Responses In Vivo
Glia · 2025-10 · 73 (10) · 2098-2129
DOI: 10.1002/glia.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 15.07.2025. Verfasst von Andrew M Lombardi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA. Hauptthemen laut MEDLINE: Nicotine, Astrocytes, Proto-Oncogene Proteins c-akt, Nicotinic Agonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
A greater understanding of the neurobiology of nicotine is needed to reduce or prevent chronic addiction, ameliorate detrimental nicotine withdrawal effects, and improve cessation rates. Nicotine binds and activates two astrocyte‐expressed nicotinic acetylcholine receptors (nAChRs), α4β2 and α7. Protein kinase B‐β (Pkb‐β or Akt2) expression is restricted to astrocytes in mice and humans and is activated by nicotine. To determine if AKT2 plays a role in astrocytic nicotinic responses, we generated astrocyte‐specific Akt2 conditional knockout (cKO) and full Akt2 KO mice. For in/ex vivo studies, we examined mice exposed to chronic nicotine for 2 weeks in drinking water (200 μg/mL) or following acute nicotine challenge (0.09, 0.2 mg/kg) after 24 h. Our in vitro studies used cultured mouse astrocytes to measure nicotine‐dependent astrocytic responses. Sholl analysis was used to measure glial fibrillary acidic protein responses in astrocytes. Our data show wild‐type (WT) mice exhibit increased astrocyte morphological complexity during acute nicotine exposure, with decreasing complexity during chronic nicotine use, whereas Akt2 cKO mice showed enhanced acute responses and reduced area following chronic exposure. In culture, we found 100 μM nicotine sufficient for morphological changes and blocking α7 or α4β2 nAChRs prevented observed morphological changes. We performed conditioned place preference (CPP) in Akt2 cKO mice, which revealed reduced nicotine preference in cKO mice compared to controls. Finally, we performed RNASeq comparing nicotine‐ and LPS‐mediated gene expression, identifying robust differences between these two astrocytic stimuli. These findings show the importance of nAChRs and AKT2 signaling in the astrocytic response to nicotine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA.
- Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA.
- Linda Crnic Institute, Anschutz Medical Center, Aurora, Colorado, USA.
ORCID-Profile: Ryan Milstead, Curtis Borski, Charles A Hoeffer
Förderung
- NIH HHS
- NIA NIH HHS
- NIDA NIH HHS
- NINDS NIH HHS
- Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Anschutz Medical Campus
- National Institutes of Health
Zitieren
APA
Lombardi, A. M., Griffioen, M., Wong, H., Milstead, R., Borski, C., Shiely, E., Bower, M. E., Schmitt, E., LaPlante, L., Ehringer, M. A., Stitzel, J., & Hoeffer, C. A. (2025). AKT2 Modulates Astrocytic Nicotine Responses In Vivo. Glia, 73(10), 2098-2129. https://doi.org/10.1002/glia.70059
Vancouver
Lombardi AM, Griffioen M, Wong H, Milstead R, Borski C, Shiely E, et al. AKT2 Modulates Astrocytic Nicotine Responses In Vivo. Glia. 2025;73(10):2098-2129. doi:10.1002/glia.70059
BibTeX
@article{Lombardi2025,
author = {Lombardi, Andrew M and Griffioen, Mina and Wong, Helen and Milstead, Ryan and Borski, Curtis and Shiely, Erin and Bower, Myra E and Schmitt, Emily and LaPlante, Lauren and Ehringer, Marissa A and Stitzel, Jerry and Hoeffer, Charles A},
title = {AKT2 Modulates Astrocytic Nicotine Responses In Vivo},
journal = {Glia},
year = {2025},
volume = {73},
number = {10},
pages = {2098--2129},
doi = {10.1002/glia.70059}
}
EUVIMED